UBS ASSET MANAGEMENT AMERICAS INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,881,514
-17.5%
407,385
-2.7%
0.01%
-25.0%
Q2 2023$15,605,8800.0%418,7250.0%0.01%0.0%
Q1 2023$15,605,880
+13.7%
418,725
+6.5%
0.01%
+14.3%
Q4 2022$13,720,283
-99.9%
393,244
-2.4%
0.01%
-46.2%
Q3 2022$22,556,076,000
+17.3%
403,075
+8.5%
0.01%
+30.0%
Q2 2022$19,223,922,000
-17.2%
371,405
+16.3%
0.01%0.0%
Q1 2022$23,211,089,000
-32.0%
319,404
+10.7%
0.01%
-23.1%
Q4 2021$34,122,765,000
-12.1%
288,589
-0.3%
0.01%
-18.8%
Q3 2021$38,811,741,000
-12.4%
289,316
+5.8%
0.02%
-15.8%
Q2 2021$44,281,091,000
+138.7%
273,492
+18.3%
0.02%
+137.5%
Q1 2021$18,554,235,000
+21.4%
231,191
-17.7%
0.01%
+14.3%
Q4 2020$15,286,344,000
+1081.6%
280,999
+331.8%
0.01%
+600.0%
Q3 2020$1,293,729,000
+2.7%
65,077
+8.6%
0.00%0.0%
Q2 2020$1,259,961,000
+111.1%
59,941
+22.8%
0.00%
Q1 2020$596,739,000
-1.1%
48,793
+18.6%
0.00%
Q4 2019$603,567,000
+5.4%
41,143
-4.1%
0.00%
Q3 2019$572,608,000
+91.6%
42,892
+135.0%
0.00%
Q2 2019$298,834,000
+20.9%
18,255
+111.4%
0.00%
Q3 2018$247,134,0008,6350.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders